Reviva Pharmaceuticals Holdings Stock Price History
| RVPHW Stock | USD 0.12 0.01 7.69% |
Below is the normalized historical share price chart for Reviva Pharmaceuticals Holdings extending back to October 18, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Reviva Pharmaceuticals stands at 0.12, as last reported on the 24th of October, with the highest price reaching 0.13 and the lowest price hitting 0.11 during the day.
If you're considering investing in Reviva Stock, it is important to understand the factors that can impact its price. Reviva Pharmaceuticals is out of control given 3 months investment horizon. Reviva Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. We have analyze and collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 15.18% are justified by taking the suggested risk. Use Reviva Pharmaceuticals Coefficient Of Variation of 1836.6, semi deviation of 18.34, and Risk Adjusted Performance of 0.0529 to evaluate company specific risk that cannot be diversified away.
At this time, Reviva Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 3.6 M in 2024, whereas Common Stock Total Equity is likely to drop 847.55 in 2024. . At this time, Reviva Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to climb to 6.36 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.03). Reviva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of October 2018 | Beta (0.09) |
Reviva |
Sharpe Ratio = 0.1181
| Best Portfolio | Best Equity | RVPHW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 128.55 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Reviva Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reviva Pharmaceuticals by adding it to a well-diversified portfolio.
Book Value (0.20) | Shares Float 26.7 M | Market Capitalization 85.8 M | Shares Short Prior Month 3.3 K | Shares Short 2.6 K |
Reviva Pharmaceuticals Stock Price History Chart
There are several ways to analyze Reviva Stock price data. The simplest method is using a basic Reviva candlestick price chart, which shows Reviva Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 24, 2024 | 0.29 |
| Lowest Price | August 15, 2024 | 0.0 |
Reviva Pharmaceuticals October 24, 2024 Stock Price Synopsis
Various analyses of Reviva Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Reviva Stock. It can be used to describe the percentage change in the price of Reviva Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Reviva Stock.| Reviva Pharmaceuticals Price Rate Of Daily Change | 0.92 | |
| Reviva Pharmaceuticals Price Daily Balance Of Power | (0.50) | |
| Reviva Pharmaceuticals Price Action Indicator | (0.01) | |
| Reviva Pharmaceuticals Accumulation Distribution | 643.69 |
Reviva Pharmaceuticals October 24, 2024 Stock Price Analysis
Reviva Stock Price History Data
The price series of Reviva Pharmaceuticals for the period between Fri, Jul 26, 2024 and Thu, Oct 24, 2024 has a statistical range of 0.29 with a coefficient of variation of 32.24. The price distribution for the period has arithmetic mean of 0.13. The median price for the last 90 days is 0.13.| Open | High | Low | Close | Volume | ||
| 10/24/2024 | 0.13 | 0.13 | 0.11 | 0.12 | 4,184 | |
| 10/23/2024 | 0.15 | 0.15 | 0.13 | 0.13 | 723.00 | |
| 10/22/2024 | 0.16 | 0.16 | 0.15 | 0.15 | 3,604 | |
| 10/21/2024 | 0.14 | 0.15 | 0.11 | 0.13 | 5,348 | |
| 10/18/2024 | 0.15 | 0.15 | 0.11 | 0.15 | 4,420 | |
| 10/17/2024 | 0.12 | 0.14 | 0.12 | 0.12 | 6,967 | |
| 10/16/2024 | 0.11 | 0.11 | 0.10 | 0.11 | 10,421 | |
| 10/15/2024 | 0.10 | 0.10 | 0.1 | 0.1 | 1,001 | |
| 10/14/2024 | 0.11 | 0.11 | 0.1 | 0.1 | 6,669 | |
| 10/11/2024 | 0.10 | 0.10 | 0.10 | 0.10 | 165.00 | |
| 10/10/2024 | 0.11 | 0.11 | 0.11 | 0.11 | 8,187 | |
| 10/09/2024 | 0.11 | 0.11 | 0.11 | 0.11 | 301.00 | |
| 10/08/2024 | 0.09 | 0.12 | 0.08 | 0.11 | 9,080 | |
| 10/07/2024 | 0.14 | 0.14 | 0.10 | 0.10 | 2,880 | |
| 10/04/2024 | 0.11 | 0.11 | 0.09 | 0.09 | 7,085 | |
| 10/03/2024 | 0.14 | 0.15 | 0.09 | 0.14 | 21,233 | |
| 10/02/2024 | 0.15 | 0.15 | 0.13 | 0.13 | 6,031 | |
| 10/01/2024 | 0.14 | 0.17 | 0.14 | 0.14 | 4,537 | |
| 09/30/2024 | 0.17 | 0.17 | 0.14 | 0.14 | 7,106 | |
| 09/27/2024 | 0.18 | 0.18 | 0.18 | 0.18 | 2.00 | |
| 09/26/2024 | 0.19 | 0.19 | 0.15 | 0.18 | 1,401 | |
| 09/25/2024 | 0.16 | 0.19 | 0.15 | 0.15 | 2,112 | |
| 09/24/2024 | 0.15 | 0.29 | 0.15 | 0.29 | 10,712 | |
| 09/23/2024 | 0.19 | 0.19 | 0.13 | 0.16 | 1,957 | |
| 09/20/2024 | 0.12 | 0.15 | 0.12 | 0.14 | 15,562 | |
| 09/19/2024 | 0.14 | 0.19 | 0.12 | 0.13 | 27,482 | |
| 09/18/2024 | 0.12 | 0.14 | 0.12 | 0.12 | 23,078 | |
| 09/17/2024 | 0.14 | 0.14 | 0.10 | 0.13 | 25,909 | |
| 09/16/2024 | 0.12 | 0.15 | 0.11 | 0.11 | 4,355 | |
| 09/13/2024 | 0.12 | 0.14 | 0.11 | 0.11 | 14,630 | |
| 09/12/2024 | 0.10 | 0.18 | 0.09 | 0.09 | 71,260 | |
| 09/11/2024 | 0.18 | 0.19 | 0.12 | 0.14 | 20,627 | |
| 09/10/2024 | 0.18 | 0.18 | 0.10 | 0.14 | 67,240 | |
| 09/09/2024 | 0.22 | 0.25 | 0.16 | 0.17 | 12,425 | |
| 09/06/2024 | 0.25 | 0.25 | 0.15 | 0.21 | 23,119 | |
| 09/05/2024 | 0.16 | 0.19 | 0.16 | 0.19 | 5,282 | |
| 09/04/2024 | 0.18 | 0.18 | 0.14 | 0.18 | 3,008 | |
| 09/03/2024 | 0.14 | 0.18 | 0.14 | 0.14 | 25,778 | |
| 08/30/2024 | 0.10 | 0.16 | 0.10 | 0.12 | 31,728 | |
| 08/29/2024 | 0.12 | 0.12 | 0.09 | 0.09 | 17,263 | |
| 08/28/2024 | 0.11 | 0.11 | 0.09 | 0.09 | 7,535 | |
| 08/27/2024 | 0.1 | 0.11 | 0.1 | 0.1 | 21,681 | |
| 08/26/2024 | 0.10 | 0.11 | 0.1 | 0.1 | 1,105 | |
| 08/23/2024 | 0.11 | 0.11 | 0.1 | 0.1 | 4,849 | |
| 08/22/2024 | 0.14 | 0.14 | 0.08 | 0.08 | 86,051 | |
| 08/21/2024 | 0.14 | 0.14 | 0.10 | 0.12 | 2,508 | |
| 08/20/2024 | 0.15 | 0.19 | 0.10 | 0.18 | 126,104 | |
| 08/19/2024 | 0.10 | 0.15 | 0.1 | 0.12 | 44,542 | |
| 08/16/2024 | 0.08 | 0.11 | 0.08 | 0.11 | 10,090 | |
| 08/15/2024 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |
| 08/14/2024 | 0.09 | 0.09 | 0.08 | 0.08 | 3,218 | |
| 08/13/2024 | 0.11 | 0.13 | 0.07 | 0.09 | 42,657 | |
| 08/12/2024 | 0.15 | 0.15 | 0.10 | 0.13 | 6,531 | |
| 08/09/2024 | 0.12 | 0.12 | 0.10 | 0.10 | 22,079 | |
| 08/08/2024 | 0.14 | 0.15 | 0.10 | 0.11 | 13,015 | |
| 08/07/2024 | 0.10 | 0.14 | 0.10 | 0.14 | 5,247 | |
| 08/06/2024 | 0.13 | 0.14 | 0.10 | 0.14 | 9,806 | |
| 08/05/2024 | 0.15 | 0.15 | 0.10 | 0.13 | 13,561 | |
| 08/02/2024 | 0.15 | 0.16 | 0.14 | 0.16 | 3,887 | |
| 08/01/2024 | 0.18 | 0.18 | 0.13 | 0.14 | 11,922 | |
| 07/31/2024 | 0.18 | 0.18 | 0.14 | 0.14 | 61,067 |
About Reviva Pharmaceuticals Stock history
Reviva Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Reviva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Reviva Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Reviva Pharmaceuticals stock prices may prove useful in developing a viable investing in Reviva Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 27.9 M | 15 M |
Reviva Pharmaceuticals Stock Technical Analysis
Reviva Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Reviva Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Reviva Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Reviva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Reviva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0529 | |||
| Jensen Alpha | 1.08 | |||
| Total Risk Alpha | (0.78) | |||
| Sortino Ratio | 0.0472 | |||
| Treynor Ratio | 1.27 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.